On December 20, 2023, Kevin Kotler resigned as a member of the board of directors of Heron Therapeutics, Inc., effective December 31, 2023. Mr. Kotler?s decision to resign was not the result of any disagreements with the Company relating to the Company?s operations, policies or practices.
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
2.96 USD | +5.34% | -1.00% | +75.29% |
05-07 | Transcript : Heron Therapeutics, Inc., Q1 2024 Earnings Call, May 07, 2024 | |
05-07 | Heron Therapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+75.29% | 423M | |
+28.81% | 49.18B | |
+1.17% | 42.11B | |
+50.47% | 40.37B | |
-5.26% | 28.85B | |
+13.81% | 26.09B | |
-22.17% | 18.71B | |
+7.91% | 13.26B | |
+32.48% | 12.32B | |
-0.29% | 11.99B |
- Stock Market
- Equities
- HRTX Stock
- News Heron Therapeutics, Inc.
- Kevin Kotler Resigns as A Member of the Board of Directors of Heron Therapeutics, Inc., Effective December 31, 2023